1. Virtual UAB NF Symposium Family Day Considered for 2021 and a Discussion of Characteristic Brain MRI Findings in NF1
  2. A Discussion of Genotype/Phenotype Correlations in NF1
  3. FDA Approves Selumetinib as First Treatment for NF1 and a Discussion of MEK Inhibitor-Based Treatments for Plexiform Neurofibromas
  4. Considerations for Individuals with NF Regarding the Novel Coronavirus
  5. The Role of Precision Medicine in NF Diagnosis and Treatment
  6. Highlights from the 2019 NF Conference and ASHG Meeting, Re-Cap of NF Walk, UAB NF Clinic News, and Final Installment of a Review of the Pediatric NF Clinical Care Resource
  7. Upcoming NF Conference and a Review of the Pediatric NF Clinical Care Resource for Neurodevelopmental Problems and Skeletal Abnormalities
  8. UAB NF Symposium Family Day and a Review of Pediatric NF Clinical Care Guidelines for Malignancies and Neurologic Issues Related to NF1
  9. NF Clinic Update and a Review of Pediatric NF Clinical Care Guidelines for Optic Pathway Gliomas and Indications for Neuroimaging in Children with NF1
  10. A Discussion of Newly Published Pediatric NF Clinical Care Guidelines
  11. Approaches to Imaging in the Diagnosis and Management of NF
  12. Explanation of a New Method for Answering NF-Related Email Questions
  13. NF Clinic Adjustments and a Discussion of the Differences Between Schwannomas and Neurofibromas
  14. Multi-Year Research Grants Awarded to UAB Investigators Pursuing Genome-Guided Therapeutics
  15. A Re-Cap of the 2018 NF Conference in Paris
  16. Highlights of Visit with Australian NF Team and Advice for Locating an Experienced NF Program
  17. Upcoming NF Conference and a Final Review of the ACMG Clinical Practice Resource
  18. A Review of ACMG Clinical Practice Resource Related to Hypertension and Vasculopathy, Osteoporosis, and Cutaneous Neurofibromas
  19. A Discussion of ACMG Clinical Practice Resource Related to Tumors Associated with NF1
  20. Highlights of the NF Forum and a Discussion of Newly Published Clinical Care Guidelines for NF1
  21. Highlights of NF Symposium and a Discussion of the Frequency of NF Clinic Visits
  22. A Focus on Improving Our Patients’ Experience and the Relationship Between Atypical Neurofibromas and Malignant Peripheral Nerve Sheath Tumors
  23. New Role as UAB Medicine’s Chief Genomics Officer, Upcoming NF Family Day, and Newly Identified Mutation/Phenotype Correlation in NF
  24. A Re-Cap of the Year’s Endeavors and a Preview of Plans for 2018
  25. Highlights of American Society of Human Genetics Meeting, Alabama NF Walk, and a Discussion of Muscle Involvement in NF1
  26. Recognizing Problems That Require Further Evaluation in Children with NF1
  27. Department of Defense NF Research Program Grant Proposals and a Review of Pain in the Context of NF
  28. Highlights of the 2017 NF Conference, NF Clinical Trials Consortium Update, and Frequently Asked Questions about Clinical Trials
  29. Development of Genome-Guided Therapeutics for NF Based on Genetic Mutation Subsets
  30. Current and Future Research Initiatives for the Treatment of Cutaneous Neurofibromas
  31. Highlights of UAB Rare Disease Genomics Symposium and a Discussion of Visual Screening in Children with NF1
  32. Continued Benefits of NF Clinic Relocations and a Discussion of Headaches in Individuals with NF1
  33. Renewed Grant for the NF Clinical Trials Consortium and a Promising New Drug for the Treatment of NF1
  34. Highlights of a Successful Year and a Look Ahead to New Goals for 2017
  35. Successful Relocation of Adult and Pediatric NF Clinics and a Discussion of Increased Breast Cancer Risk in Women with NF1
  36. A Successful 3rd Annual Alabama NF Walk and a Discussion of Developmental Issues and Cognitive Function in NF1
  37. Highlights of NF Symposium, Plans for 3rd Annual NF Walk, Discussion of Mosaic NF1, and a Review of the NF Neurologic Exam
  38. Upcoming NF Symposium at Children’s Harbor, Applications of New Gene Editing Technology, and a Review of the NF Extremities Exam
  39. NF Clinic Genetics Counselor Receives Esteemed Scholars Award, Re-Cap of NF Forum, and What to Expect During an NF Genital Exam
  40. Upcoming NF Symposium, Enhanced Patient Exam Procedure, and a Review of the NF Abdominal Exam
  41. Sources of Variability in NF and What to Expect During an NF Chest Examination
  42. Re-Cap of Meetings in Washington, DC, for Renewed NF Research Funding and a Review of What to Expect During an NF Neck Exam
  43. New Discoveries in the UAB Medical Genomics Laboratory, Animal Model Progress, and NF-Related Features of the Head
  44. New Year’s Resolutions for the NF Program and Common Skin Issues Detected During an NF Clinic Visit
  45. Animal Model Research Update, Plans for Adult and Pediatric NF Clinics, and the Focus of Exams in an NF Clinic
  46. Successful 2nd Annual Alabama NF Walk and Update on Newly Formed NF Community Advisory Board
  47. Upcoming 2nd Annual Alabama NF Walk and Understanding the Role of NF Genetic Testing
  48. A Successful and Memorable NF Family Day and Plans for Future Dermal Neurofibroma Trials
  49. A New Specialist Joins the NF Clinic Team, Upcoming NF Symposium at UAB, and Understanding RAS Disorders and their Relationship to NF
  50. Understanding Possible Explanations for Isolated Features of NF
  51. Responding to E-mailed Questions from Patients and Reviewing Diagnostic Criteria for Café-Au-Lait Spots and Groin Freckling
  52. Measurement Technique for Dermal Neurofibromas Validated at UAB Expands Possibilities for Clinical Trials
  53. Birmingham Family Affected by NF Recognized at CTF BeNeFit II Gala in Detroit, and Frequently Asked Patient Questions Regarding NF Clinical Trials
  54. Highlights of NF Family Day and Encouraging Developments from an International NF Meeting
  55. Upcoming NF Family Day, Research Advances, and a Special Award for a Birmingham Family Affected by NF
  56. A Successful NF Walk, Two Key NF Conferences, and Rapid Research Progress
  57. A new website and Birmingham's first NF walk